Fred E Cooperrider

Array ( [id] => 4071894 [patent_doc_number] => 05965396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Human lymph node derived GTPase' [patent_app_type] => 1 [patent_app_number] => 9/006535 [patent_app_country] => US [patent_app_date] => 1998-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17742 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965396.pdf [firstpage_image] =>[orig_patent_app_number] => 006535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383059 [patent_doc_number] => 06262033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Remedy for diseases associated with NF-.kappa.B' [patent_app_type] => 1 [patent_app_number] => 8/945805 [patent_app_country] => US [patent_app_date] => 1998-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3457 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262033.pdf [firstpage_image] =>[orig_patent_app_number] => 945805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4195786 [patent_doc_number] => 06013447 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Random intracellular method for obtaining optimally active nucleic acid molecules' [patent_app_type] => 1 [patent_app_number] => 8/976220 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11480 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013447.pdf [firstpage_image] =>[orig_patent_app_number] => 976220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994745 [patent_doc_number] => 05892023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Anti sense oligonucleotides for blocking IgE receptor synthesis' [patent_app_type] => 1 [patent_app_number] => 8/952597 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1865 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892023.pdf [firstpage_image] =>[orig_patent_app_number] => 952597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002281 [patent_doc_number] => 06004813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Il-6 activity inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/945726 [patent_app_country] => US [patent_app_date] => 1997-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004813.pdf [firstpage_image] =>[orig_patent_app_number] => 945726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174427 [patent_doc_number] => 06083923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Liposomal oligonucleotide compositions for modulating RAS gene expression' [patent_app_type] => 1 [patent_app_number] => 8/961469 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 23773 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083923.pdf [firstpage_image] =>[orig_patent_app_number] => 961469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190274 [patent_doc_number] => 06043077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Hepatitis C virus ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/954210 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 35 [patent_no_of_words] => 13825 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043077.pdf [firstpage_image] =>[orig_patent_app_number] => 954210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645760 [patent_doc_number] => 06472209 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Using polyamide nucleic acid oligomers to engender a biological response' [patent_app_type] => B1 [patent_app_number] => 08/953269 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8318 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472209.pdf [firstpage_image] =>[orig_patent_app_number] => 08953269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408322 [patent_doc_number] => 06271369 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Chimeric molecules targeted to viral RNAs' [patent_app_type] => 1 [patent_app_number] => 8/950196 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24519 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271369.pdf [firstpage_image] =>[orig_patent_app_number] => 950196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4069622 [patent_doc_number] => 06068972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents' [patent_app_type] => 1 [patent_app_number] => 8/946225 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8561 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/068/06068972.pdf [firstpage_image] =>[orig_patent_app_number] => 946225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940738 [patent_doc_number] => 05989904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Selective inhibition of internally initiated RNA translation' [patent_app_type] => 1 [patent_app_number] => 8/817953 [patent_app_country] => US [patent_app_date] => 1997-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 31 [patent_no_of_words] => 19710 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989904.pdf [firstpage_image] =>[orig_patent_app_number] => 817953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795441 [patent_doc_number] => 05780612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Oligonucleotides specific for cytokine signal transducer gp130 mRNA' [patent_app_type] => 1 [patent_app_number] => 8/943834 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5852 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780612.pdf [firstpage_image] =>[orig_patent_app_number] => 943834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950002 [patent_doc_number] => 05977340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Antisense oligonucleotides for inhibiting helicobacter pylori activity' [patent_app_type] => 1 [patent_app_number] => 8/930371 [patent_app_country] => US [patent_app_date] => 1997-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2854 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977340.pdf [firstpage_image] =>[orig_patent_app_number] => 930371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784160 [patent_doc_number] => 05840497 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method for specific silencing of genes by DNA methylation' [patent_app_type] => 1 [patent_app_number] => 8/937583 [patent_app_country] => US [patent_app_date] => 1997-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1409 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840497.pdf [firstpage_image] =>[orig_patent_app_number] => 937583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3853308 [patent_doc_number] => 05767264 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Oligodeoxynucleotides containing 5-alkyl, 5-(1-alkenyl)- and 5-(1-alkynl) pyrimidines' [patent_app_type] => 1 [patent_app_number] => 8/934852 [patent_app_country] => US [patent_app_date] => 1997-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 7394 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767264.pdf [firstpage_image] =>[orig_patent_app_number] => 934852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176965 [patent_doc_number] => 06084090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Human papilloma virus anti-sense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/929140 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7625 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/084/06084090.pdf [firstpage_image] =>[orig_patent_app_number] => 929140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 489053 [patent_doc_number] => 07214525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-08 [patent_title] => 'Pesticidal agents' [patent_app_type] => utility [patent_app_number] => 09/242843 [patent_app_country] => US [patent_app_date] => 1997-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 3 [patent_no_of_words] => 6003 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/214/07214525.pdf [firstpage_image] =>[orig_patent_app_number] => 09242843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4084669 [patent_doc_number] => 06132954 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Methods of screening for agents that delay a cell cycle and compositions comprising era and an analogue of wild-type era' [patent_app_type] => 1 [patent_app_number] => 8/915498 [patent_app_country] => US [patent_app_date] => 1997-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 40 [patent_no_of_words] => 24708 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132954.pdf [firstpage_image] =>[orig_patent_app_number] => 915498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950032 [patent_doc_number] => 05977343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Synthesis, deprotection, analysis and purification of RNA and ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/911869 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 12433 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977343.pdf [firstpage_image] =>[orig_patent_app_number] => 911869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4203497 [patent_doc_number] => 06077668 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Highly sensitive multimeric nucleic acid probes' [patent_app_type] => 1 [patent_app_number] => 8/910632 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28546 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077668.pdf [firstpage_image] =>[orig_patent_app_number] => 910632 [rel_patent_id] =>[rel_patent_doc_number] =>)